Skip to main content
Liberty Jenkins, M.D., MRCP, MA

Liberty Jenkins, M.D., MRCP, MA

Investigator

Dr. Jenkins is a neuromuscular and general neurologist and director of the Amyotrophic Lateral Sclerosis Clinic at the Forbes Norris MDA/ALS Research and Treatment Center.

After graduating from Cambridge University with a degree in physiology, Dr. Jenkins went on to earn a Bachelor of Medicine and Surgery with Honors (cum laude) from Edinburgh University. She received multiple academic scholarships and prizes from Cambridge and Edinburgh, including first-class honors.

Subsequently, she completed her internship at the Royal Infirmary of Edinburgh in Scotland, United Kingdom, and then her residency at the Oxford University Hospital. Following her residency and internship training, Dr. Jenkins completed various fellowships, including a peripheral nerve fellowship at the National Hospital for Neurology and Neurosurgery in London, a neuromuscular clinical research (ALS) fellowship at the Forbes Norris ALS/MDA Center in San Francisco, California, a fellowship in clinical neurophysiology at Stanford University Hospital in Stanford, California, and a neuromuscular fellowship at the Stanford University Hospital.

Dr. Jenkins specializes in ALS, neuromuscular disease and electromyography (EMG). Her most recent publication is a book on the diagnosis of ALS that she co-authored with Martin Turner. Dr. Jenkins has also published works related to the study of phrenic nerve conduction as a biomarker of respiratory insufficiency in ALS and other topics related to the diagnosis of ALS, muscle disorders and peripheral nerve disease.

Her research interests have led her to travel widely and collaborate with international colleagues. In addition to her work in the United State, the United Kingdom and Australia, she has worked in pediatrics in rural Nepal, at the Peto Institute in Budapest, Hungary, and with village polio immunization programs in Zimbabwe. Dr. Jenkins enjoys running, skiing, reading and cooking.

Publications and Books / Book Chapters:

“Fast Facts Series: Diagnosing Amyotrophic Lateral Sclerosis” Jenkins L & Turner M (2019)

“Muscle disorders” Mathew L. Oxford Diagnosis and Treatment in Internal Medicine, edited by Patrick Davey and David Sprigings (Oxford University Press, 2018)

"Peripheral nerve disease” Mathew L. Oxford Diagnosis and Treatment in Internal Medicine, edited by Patrick Davey and David Sprigings (Oxford University Press, 2018)

Research studies

Clinical trials

  • HEALEY ALS Platform Trial

    Status: Closed to Enrollment

  • Intermediate-size Patient Population Expanded Access Protocol for SPG302 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)

    Status: Open to Enrollment

  • Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, 24-Week Study With Additional 24-Week Blinded Active Extension to Evaluate the Safety and Efficacy of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

    Status: Open to Enrollment

  • A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Pridopidine in Participants With Amyotrophic Lateral Sclerosis

    Status: Open to Enrollment

  • A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Usnoflast Administered to Adult Subjects With ALS UNITE-ALS USNO.24.002

    Status: Open to Enrollment

Page 1 of 2

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?